Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0002 Transporter Info | ||||
Gene Name | ABCC2 | ||||
Transporter Name | Multidrug resistance-associated protein 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class 1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to ABCC2 gene | [1] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
Tissue |
Bone | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the ABCC2 gene, which in turn affects the expression or function of the drug transporter Multidrug resistance-associated protein 2. | |||||
NFE2L2 |
Click to Show/Hide to Show 5 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of ABCC2 gene in health condition | [2] | ||||
TF Protein Name |
Nuclear factor erythroid 2-related factor 2 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Arsenic | |||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Liver | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
Human hepatocytes | |||||
Detailed Description |
Nuclear factor erythroid 2-related factor 2 (NFE2L2), influenced by the exogenous arsenic, has been reported to activate the transcription of ABCC2 gene in health condition , which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Transcriptional Phenomenon 2 |
Activation of ABCC2 gene in hepatoblastoma condition | [3] | ||||
TF Protein Name |
Nuclear factor erythroid 2-related factor 2 | Transcription Factor Info | ||||
Studied Phenotype |
Hepatoblastoma [ICD11: 2C12.01] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human hepatoblastoma cells (HepG2) | |||||
Detailed Description |
Nuclear factor erythroid 2-related factor 2 (NFE2L2) has been reported to activate the transcription of ABCC2 gene in hepatoblastoma condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Transcriptional Phenomenon 3 |
Activation of ABCC2 gene in health condition | [4] | ||||
TF Protein Name |
Nuclear factor erythroid 2-related factor 2 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Liver | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
C57/B6 mice | |||||
Detailed Description |
Nuclear factor erythroid 2-related factor 2 (NFE2L2), influenced by the exogenous arsenic, has been reported to activate the transcription of ABCC2 gene in health condition , which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Transcriptional Phenomenon 4 |
Activation of ABCC2 gene in brain neuroblastoma condition | [5] | ||||
TF Protein Name |
Nuclear factor erythroid 2-related factor 2 | Transcription Factor Info | ||||
Studied Phenotype |
Brain neuroblastoma [ICD11: 2A00.11] | |||||
Tissue |
Brain | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
Human neuroblastoma cells (SH-SY5Y) | |||||
Detailed Description |
Nuclear factor erythroid 2-related factor 2 (NFE2L2), influenced by the exogenous arsenic, has been reported to activate the transcription of ABCC2 gene in brain neuroblastoma condition , which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Transcriptional Phenomenon 5 |
Activation of ABCC2 gene in health condition | [6] | ||||
TF Protein Name |
Nuclear factor erythroid 2-related factor 2 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/6 mice | |||||
Detailed Description |
Nuclear factor erythroid 2-related factor 2 (NFE2L2) has been reported to activate the transcription of ABCC2 gene in health condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Class 1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
AHR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of ABCC2 gene in health condition | [6] | ||||
TF Protein Name |
Aryl hydrocarbon receptor | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/6 mice | |||||
Detailed Description |
Aryl hydrocarbon receptor (AHR) has been reported to activate the transcription of ABCC2 gene in health condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Class 2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 5 TF(s) Regulating This DT |
|||||
ESR1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Repression of ABCC2 gene in breast cancer condition | [7] | ||||
TF Protein Name |
Estrogen receptor | Transcription Factor Info | ||||
Studied Phenotype |
Breast cancer [ICD11: 2C60-2C6Z] | |||||
Tissue |
Breast | |||||
Related DT Changes |
down regulating | |||||
Experimental Material |
Human breast carcinoma cells (MCF-7) | |||||
Detailed Description |
Estrogen receptor (ESR1), influenced by the exogenous fulvestrant, has been reported to repress the transcription of ABCC2 gene in breast cancer condition , which leads to a decreased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
NR1H4 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of ABCC2 gene in hepatoblastoma condition | [8] | ||||
TF Protein Name |
Bile acid receptor | Transcription Factor Info | ||||
Studied Phenotype |
Hepatoblastoma [ICD11: 2C12.01] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human hepatoblastoma cells (HepG2) | |||||
Detailed Description |
Bile acid receptor (NR1H4) has been reported to activate the transcription of ABCC2 gene in hepatoblastoma condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Transcriptional Phenomenon 2 |
Activation of ABCC2 gene in health condition | [9] | ||||
TF Protein Name |
Bile acid receptor | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Liver | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
Male mice | |||||
Detailed Description |
Bile acid receptor (NR1H4), influenced by the exogenous lithocholic acid, has been reported to activate the transcription of ABCC2 gene in health condition , which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
NR1I2 |
Click to Show/Hide to Show 6 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of ABCC2 gene in hepatoblastoma condition | [8] | ||||
TF Protein Name |
Nuclear receptor subfamily 1 group I member 2 | Transcription Factor Info | ||||
Studied Phenotype |
Hepatoblastoma [ICD11: 2C12.01] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human hepatoblastoma cells (HepG2) | |||||
Detailed Description |
Nuclear receptor subfamily 1 group I member 2 (NR1I2) has been reported to activate the transcription of ABCC2 gene in hepatoblastoma condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Transcriptional Phenomenon 2 |
Activation of ABCC2 gene in cholestatic liver disease condition | [10] | ||||
TF Protein Name |
Nuclear receptor subfamily 1 group I member 2 | Transcription Factor Info | ||||
Studied Phenotype |
Cholestatic liver disease [ICD11: DB99] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/6 mice | |||||
Detailed Description |
Nuclear receptor subfamily 1 group I member 2 (NR1I2) has been reported to activate the transcription of ABCC2 gene in cholestatic liver disease condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Transcriptional Phenomenon 3 |
Activation of ABCC2 gene in health condition | [11] | ||||
TF Protein Name |
Nuclear receptor subfamily 1 group I member 2 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Liver | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
C57BL/6 mice | |||||
Detailed Description |
Nuclear receptor subfamily 1 group I member 2 (NR1I2), influenced by the exogenous resveratrol, has been reported to activate the transcription of ABCC2 gene in health condition , which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Transcriptional Phenomenon 4 |
Activation of ABCC2 gene in hepatocellular carcinoma condition | [12] | ||||
TF Protein Name |
Nuclear receptor subfamily 1 group I member 2 | Transcription Factor Info | ||||
Studied Phenotype |
Hepatocellular carcinoma [ICD11: 2C12.02] | |||||
Tissue |
Liver | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
Human hepatocellular carcinoma (HepaRG) | |||||
Detailed Description |
Nuclear receptor subfamily 1 group I member 2 (NR1I2), influenced by the exogenous resveratrol, has been reported to activate the transcription of ABCC2 gene in hepatocellular carcinoma condition , which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Transcriptional Phenomenon 5 |
Activation of ABCC2 gene in bile duct obstruction condition | [13] | ||||
TF Protein Name |
Nuclear receptor subfamily 1 group I member 2 | Transcription Factor Info | ||||
Studied Phenotype |
Bile duct obstruction [DC10.02] | |||||
Tissue |
Liver | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
Wistar rats | |||||
Detailed Description |
Nuclear receptor subfamily 1 group I member 2 (NR1I2), influenced by the exogenous resveratrol, has been reported to activate the transcription of ABCC2 gene in bile duct obstruction condition , which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Transcriptional Phenomenon 6 |
Activation of ABCC2 gene in health condition | [14] | ||||
TF Protein Name |
Nuclear receptor subfamily 1 group I member 2 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Duodenum | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
Human duodenal mucosa biopsy specimens | |||||
Detailed Description |
Nuclear receptor subfamily 1 group I member 2 (NR1I2), influenced by the exogenous resveratrol, has been reported to activate the transcription of ABCC2 gene in health condition , which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
NR1I3 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of ABCC2 gene in hepatoblastoma condition | [15] | ||||
TF Protein Name |
Nuclear receptor subfamily 1 group I member 3 | Transcription Factor Info | ||||
Studied Phenotype |
Hepatoblastoma [ICD11: 2C12.01] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human hepatoblastoma cells (HepG2) | |||||
Detailed Description |
Nuclear receptor subfamily 1 group I member 3 (NR1I3) has been reported to activate the transcription of ABCC2 gene in hepatoblastoma condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Transcriptional Phenomenon 2 |
Activation of ABCC2 gene in health condition | [6] | ||||
TF Protein Name |
Nuclear receptor subfamily 1 group I member 3 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/6 mice | |||||
Detailed Description |
Nuclear receptor subfamily 1 group I member 3 (NR1I3) has been reported to activate the transcription of ABCC2 gene in health condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
PPARA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of ABCC2 gene in health condition | [16] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor alpha | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Brain | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
Sprague Dawley rats | |||||
Detailed Description |
Peroxisome proliferator-activated receptor alpha (PPARA), influenced by the exogenous perfluorooctane sulfonic acid, has been reported to activate the transcription of ABCC2 gene in health condition , which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Class 3.1: Homeo domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
HNF1A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of ABCC2 gene in sepsis condition | [17] | ||||
TF Protein Name |
Hepatocyte nuclear factor 1-alpha | Transcription Factor Info | ||||
Studied Phenotype |
Sepsis [ICD11: 1G40-1G41] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/6 mice | |||||
Detailed Description |
Hepatocyte nuclear factor 1-alpha (HNF1A) has been reported to activate the transcription of ABCC2 gene in sepsis condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
ONECUT1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of ABCC2 gene in health condition | [18] | ||||
TF Protein Name |
Hepatocyte nuclear factor 6 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Mouse liver hepatic sinusoidal endothelial cells (SV40LG) | |||||
Detailed Description |
Hepatocyte nuclear factor 6 (ONECUT1) has been reported to activate the transcription of ABCC2 gene in health condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Class 3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to ABCC2 gene | [19] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Tissue |
Breast; Liver; Lung; Pancreatic ductal; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the ABCC2 gene, which in turn affects the expression or function of the drug transporter Multidrug resistance-associated protein 2. | |||||
Class 3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
IRF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of ABCC2 gene in hepatoblastoma condition | [20] | ||||
TF Protein Name |
Interferon regulatory factor 3 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Actinomycin D | |||||
Studied Phenotype |
Hepatoblastoma [ICD11: 2C12.01] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human hepatoblastoma cells (HepG2) | |||||
Detailed Description |
Interferon regulatory factor 3 (IRF3) has been reported to activate the transcription of ABCC2 gene in hepatoblastoma condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
SPI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to ABCC2 gene | [21] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Brain; Breast; Embryo; Foreskin; Intestine; Kidney; Lung; Muscle; Penis; Placenta; Renal cortex; Renal pelvis; Skin; Umbilical cord blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) can directly bind to the ABCC2 gene, which in turn affects the expression or function of the drug transporter Multidrug resistance-associated protein 2. | |||||
Class 6.7: Grainyhead domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GRHL2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to ABCC2 gene | [22] | ||||
TF Protein Name |
Grainyhead-like protein 2 homolog | Transcription Factor Info | ||||
Tissue |
Breast; Bronchus; Ovary | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Grainyhead-like protein 2 homolog (GRHL2) can directly bind to the ABCC2 gene, which in turn affects the expression or function of the drug transporter Multidrug resistance-associated protein 2. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.